DANIPHARM A/S — Credit Rating and Financial Key Figures

DANIPHARM A/S (CVR number: 12335040) is a company from TÅRNBY. The company recorded a gross profit of 37.6 mDKK in 2024. The operating profit was 17.1 mDKK, while net earnings were 13.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was 18.9 %, which can be considered excellent and Return on Equity (ROE) was 25.7 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 55 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. DANIPHARM A/S's liquidity measured by quick ratio was 2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.